
BRAF (gene) - Wikipedia
BRAF is a human gene that encodes a protein called B-Raf. The gene is also referred to as proto-oncogene B-Raf and v-Raf murine sarcoma viral oncogene homolog B, while the protein is …
BRAF Mutation and Cancer - Johns Hopkins Medicine
The BRAF gene provides instructions to a protein responsible for managing important cell functions related to growth. If there is a mutation in the gene, it stops working correctly and …
BRAF
Apr 16, 2024 · In this review, we cover the current understanding of BRAF mutations and associated clinical characteristics in patients with metastatic NSCLC, approved and emerging …
BRAF gene: From human cancers to developmental syndromes
The BRAF gene encodes for a serine/threonine protein kinase that participates in the MAPK/ERK signalling pathway and plays a vital role in cancers and developmental syndromes …
BRAF Mutation: Cancer Types, Testing, Treatment - Verywell Health
Sep 15, 2025 · BRAF mutations are present in many melanomas as well as some lung cancers, colon cancers, and more. Learn about the basics, testing, and treatment.
BRAF Gene - GeneCards | BRAF Protein | BRAF Antibody
Jan 14, 2026 · BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with BRAF include Lung Cancer and Cardiofaciocutaneous …
BRAF gene: MedlinePlus Genetics
The BRAF gene provides instructions for making a protein that helps transmit chemical signals from outside the cell to the cell's nucleus. Learn about this gene and related health conditions.
BRAF in Melanoma - AIM at Melanoma Foundation
If you have a mutation in your BRAF gene, melanoma cells will make an altered form of protein that allows them to grow out of control. Approximately 50% of all melanoma patients who are …
BRAF and Lung Cancer - American Lung Association
Dec 2, 2025 · BRAF is one type of lung cancer biomarker. BRAF is the name of both a gene and a protein. The BRAF protein helps control cell growth. When there is a mutation in the BRAF …
Efficacy of combined BRAF-MEK inhibitor second-line therapy in …
Jan 1, 2026 · Randomised trials recently showed that sequencing of first-line (1 L) immune checkpoint inhibitor (ICI) and second-line (2 L) BRAF-MEK-inhibitor (BRAF/MEKi) combination …